Longeveron Announces 2026 Third Quarter Financial Results and Provides Business Update
Stephen WillardMIAMI, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. NASDAQ:LGVN, a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today reported financial results for the quarter ended September 30, 202…